T | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For
the period ended June 30, 2007
|
||
* | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE Act of 1934 | |
For
the transition period from ___ to
___.
|
NEVADA |
98-0351508 |
|||
(State
or other jurisdiction of incorporation) |
(IRS
Employer |
|||
Identification
No.) |
PART1-FINANCIAL
INFORMATION
|
||
Item
1:
|
FINANTIAL
STATEMENTS:
|
|
4
|
||
5
|
||
6
|
||
7
|
||
Notes to Financial Statements (unaudited) |
8
|
|
Item
2:
|
9
|
|
Item
3:
|
12
|
|
PART2-OTHER
INFORMATION
|
||
Item
1:
|
13
|
|
Item
2:
|
13
|
|
Item
3:
|
13
|
|
Item
4:
|
13
|
|
Item
5:
|
13
|
|
Item
6:
|
13
|
|
14
|
ITEM 1. |
FINANCIAL
STATEMENTS
|
June 30,
2007
(Unaudited)
|
December 31,
2006
(Audited)
|
||||||
ASSETS
|
|||||||
Current
Assets:
|
|||||||
Cash
|
$
|
-
|
$
|
1,357
|
|||
Total
current assets
|
-
|
1,357
|
|||||
Fixed
Assets:
|
|||||||
Automobile
|
1,500
|
1,500
|
|||||
Less
accumulated depreciation
|
1,428
|
1,356
|
|||||
Net
fixed assets
|
72
|
144
|
|||||
|
|
||||||
Total
Assets
|
$
|
72
|
$
|
1,501
|
|||
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
|||||||
Current
Liabilities:
|
|||||||
Accounts Payable
|
$
|
211
|
$
|
-
|
|||
Accrued Expenses
|
2,415
|
2,415
|
|||||
Rent Payable
|
3,750
|
3,750
|
|||||
Advances from Shareholders
|
130,000
|
120,000
|
|||||
Other Advances
|
99,900
|
99,900
|
|||||
Total current liabilities
|
236,276
|
226,065
|
|||||
Stockholders’
Deficit:
|
|||||||
Common
Stock: authorized 100,000,000 shares of $.001
par value; 46,676,400 shares issued and outstanding
|
46,506
|
46,506
|
|||||
Additional
paid-in capital
|
490,894
|
490,894
|
|||||
Deficit
accumulated during development stage
|
(773,604)
|
(761,964)
|
|||||
Total
stockholders’ deficit
|
(236,204)
|
(224,564)
|
|||||
Total
Liabilities and Stockholders’ Deficit
|
$
|
72
|
$
|
1,501
|
Six Months Periods Ended June 30,
|
December
1, 1997
(Date
of Inception)
To
September 30,
|
|||||||||
2007
|
2006
|
2007
|
||||||||
Revenue
|
$
|
-
|
$
|
-
|
$
|
91,912
|
||||
Expenses
|
11,640
|
29,997
|
765,442
|
|||||||
Impairment Charge - write down of licensing agreement
|
-
|
-
|
103,528
|
|||||||
Operating
loss
|
(11,640
|
)
|
(29,997
|
)
|
(777,058
|
)
|
||||
Other
Income - Interest
|
-
|
32
|
3,454
|
|||||||
Loss
accumulated during development stage
|
$
(11,640
|
)
|
$
(29,965
|
)
|
$
(773,604
|
)
|
||||
Loss
Per Share -
|
||||||||||
Basic
and Diluted
|
$
|
-
|
$
|
-
|
||||||
Average
shares outstanding
|
46,676,400
|
46,676,400
|
Three Months Periods Ended June 30,
|
December
1, 1997
(Date
of Inception)
To
September 30,
|
|||||||||
2007
|
2006
|
2007
|
||||||||
Revenue
|
$
|
-
|
$
|
-
|
$
|
91,912
|
||||
Expenses
|
10,990
|
4,251
|
765,442
|
|||||||
Impairment Charge - write down of licensing agreement
|
-
|
-
|
103,528
|
|||||||
Operating
loss
|
(10,990
|
)
|
(4,251
|
)
|
(777,058
|
)
|
||||
Other
Income - Interest
|
-
|
-
|
3,454
|
|||||||
Loss
accumulated during development stage
|
$
(10,990
|
)
|
$
(4,251
|
)
|
$
(773,604
|
)
|
||||
Loss
Per Share -
|
||||||||||
Basic
and Diluted
|
$
|
-
|
$
|
-
|
||||||
Average
shares outstanding
|
46,676,400
|
46,676,400
|
Quarters Ended
June 30
|
December
1, 1997
(Date
of Inception)
|
|||||||||
2007
|
2006
|
To
June 30, 2007
|
||||||||
CASH
FLOWS FROM OPERATIONS:
|
||||||||||
Net
loss
|
$
|
(11,640
|
)
|
$
|
(29,965
|
)
|
$
|
(773,604
|
)
|
|
Charges
not requiring the outlay of cash:
|
||||||||||
Depreciation
and amortization
|
72
|
4,788
|
57,900
|
|||||||
Impairment of Licensing Agreement
|
-
|
-
|
21,300
|
|||||||
Common stock issued for services
|
-
|
-
|
103,528
|
|||||||
Changes
in assets and liabilities:
|
||||||||||
Increase (Decrease)
in accrued liabilities
|
-
|
7,484 |
6,165
|
|||||||
Increase in accounts payables
|
211
|
- |
211
|
|||||||
Net
Cash Consumed By Operating
Activities
|
(11,357)
|
(17,693)
|
(584,500)
|
|||||||
|
||||||||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
||||||||||
Purchase
of automobile
|
-
|
-
|
(1,500
|
)
|
||||||
Payment
of amount due for licensing agreement
|
-
|
-
|
(160,000
|
)
|
||||||
|
||||||||||
Net
Cash Consumed By Investing
Activities
|
-
|
-
|
(161,500
|
)
|
||||||
|
||||||||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
||||||||||
Advance received
|
-
|
-
|
99,900
|
|||||||
Issuances of common stock
|
-
|
-
|
446,100
|
|||||||
Shareholder deposits for common stock
|
-
|
-
|
70,000
|
|||||||
Shareholder
advance
|
10,000
|
110,000
|
210,000
|
|||||||
Repayment of shareholder advances
|
-
|
-
|
(80,000)
|
|||||||
Advances from affiliate
|
-
|
100,000
|
200,000
|
|||||||
Repayment of advances from affiliate
|
|
(200,000)
|
(200,000)
|
|||||||
Net
Cash Provided By Financing
Activities
|
10,000
|
10,000
|
746,000
|
|||||||
|
||||||||||
Net
Change In Cash
|
(1,357
|
)
|
(7,693
|
)
|
-
|
|||||
|
||||||||||
Cash
balance, beginning of period
|
1,357
|
7,693
|
-
|
|||||||
|
|
|||||||||
Cash
balance, end of period
|
$
|
-
|
$
|
-
|
$
|
-
|
1.
|
BASIS
OF PRESENTATION
|
2.
|
GOING CONCERN UNCERTAINTY
|
The Company's plan of operations for the next 12 months was to help Evader
refine it's electric scooter implementing Amanasu's proprietary rapid battery
charging technology; however, due to recent marketing research Evader's
original product did not meet the Company's standards, which the Company
felt were required to compete successful in the Japanese, and southeast Asian markets. Pixen under went a name change and is now known as Seems Inc.
Seems Inc. will retain the name Pixen as a brand name for its products. The project with Seems has hit two barriers. Seems has collected
sufficient funds and attained the requirements to become public in Japan; however, the company analysis has taken longer than expected and
Seems has been informed that it may take another 6-12 months before it can be listed. Secondly, the United States does not recognize
Japanese health certifications, and Seems' products must be reapproved by the FDA. Amanasu Technologies as taken the initial steps and
received the MDUFMA Small Business Qualification in order to reduce cost for pre-market approval, and is currently collecting product
data and translating it into english to submit its first PMA. The cost of this project is taken into account in the estimated expenditures
for the 2007 fiscal year ending December 31, 2007. The approval of the DAA is believed to take no more than 8-12 months; however,
the scent scenor is believed to be a FDA Class 3 medical device, which may take longer. The most recent partnership of the Company and A.W.I is in the process of discussions; however, FDA pre-market approval for its
water purification solution is being prepared.
The original plan was to have Evader assume responsibility for the management of
customer service related issues because Evader already had such a system
established. The Company would in turn provide it's own technologies, and assume
responsibility of marketing Evader's product. While refinements were done,
the Company would market Evader's original product to generate revenue.
The Company came about two marketing channels: the first being the biggest
dealer of used motorcycles in Japan; and the second a used automobile agent.
Negotiations with both parties have proceeded since August 2005, and if an
agreement could be reached, the Company would have distribution to 1500 to
2000 retail outlets across Japan. Marketing through these channels may have
also proved to be a good testing ground for Evader's electric scooter. On August
26th, 2005 shipped one proto-type unit to Japan; however, the approval by
the Japan Ministry of Land, Infrastructure, and Transport for use of the vehicle
was rejected due to an unqualified battery structure. With the rejection,
and the product's lack of marketability the Company has decided to put
this project on hold until more resources can be attained or if the Company
is able to come in contact with more a suitable Company to collaborate with.
Since an unsuccessful partnership with Evader, the Company has returned back to its
electric scooter with its patented short battery charge time. The Company has decided
to continue research and development in order to further improve and refine the electric scooter's battery
and also to lower the electric scooters price. The Company believes that efficient battery operation,
and low sale price, are key to a commercially viable product.
The project with Seems Inc has not bee moving as scheduled. Seems has delayed in becoming public due to
stringent analysis of its company and expects to become public in early 2008. Since pre-market approval is required by the FDA,
launching Seems' products will take 8-12 months, providing the FDA grants approval.
(i)
|
this quarterly report on Form 10 QSB contains any untrue statement
of a material fact or omits to state a material fact necessary
to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the
period covered by this quarterly report on Form 10 QSB, and (ii) the
financial statements, and other financial information included in this
quarterly report on Form 10 QSB, fairly present in all material respects
the financial condition, results of operations and cash flows of the
Company as of, and for, the periods presented in this quarterly report
on Form 10 QSB.
|